Massachusetts Financial Services Co. MA Has $74.75 Million Holdings in Teleflex Incorporated $TFX

Massachusetts Financial Services Co. MA lessened its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 1.3% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 610,933 shares of the medical technology company’s stock after selling 7,788 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 1.38% of Teleflex worth $74,754,000 at the end of the most recent quarter.

A number of other large investors also recently made changes to their positions in TFX. Empowered Funds LLC boosted its holdings in shares of Teleflex by 15.8% during the first quarter. Empowered Funds LLC now owns 1,684 shares of the medical technology company’s stock worth $233,000 after purchasing an additional 230 shares during the period. Jane Street Group LLC lifted its position in Teleflex by 42.6% in the 1st quarter. Jane Street Group LLC now owns 6,343 shares of the medical technology company’s stock worth $877,000 after buying an additional 1,895 shares in the last quarter. Parallel Advisors LLC boosted its stake in shares of Teleflex by 43.1% during the 2nd quarter. Parallel Advisors LLC now owns 455 shares of the medical technology company’s stock valued at $54,000 after buying an additional 137 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in shares of Teleflex by 759.8% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 27,135 shares of the medical technology company’s stock valued at $3,253,000 after acquiring an additional 23,979 shares in the last quarter. Finally, CX Institutional grew its holdings in shares of Teleflex by 14.7% during the 2nd quarter. CX Institutional now owns 872 shares of the medical technology company’s stock valued at $103,000 after acquiring an additional 112 shares in the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Wall Street Analysts Forecast Growth

TFX has been the subject of several recent research reports. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a report on Monday, December 29th. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Tuesday, December 9th. Wall Street Zen downgraded Teleflex from a “buy” rating to a “hold” rating in a report on Saturday, November 15th. Royal Bank Of Canada reiterated a “sector perform” rating and issued a $135.00 target price on shares of Teleflex in a research note on Wednesday, December 17th. Finally, Zacks Research downgraded shares of Teleflex from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, September 30th. One investment analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and two have assigned a Sell rating to the company. Based on data from MarketBeat.com, Teleflex presently has an average rating of “Reduce” and a consensus price target of $142.43.

Teleflex Stock Performance

Shares of NYSE TFX opened at $100.26 on Wednesday. The business’s 50-day simple moving average is $116.59 and its 200-day simple moving average is $120.34. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.53 and a current ratio of 2.57. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $185.94. The firm has a market cap of $4.43 billion, a price-to-earnings ratio of -13.64, a P/E/G ratio of 1.34 and a beta of 0.93.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, November 6th. The medical technology company reported $3.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $3.38 by $0.29. Teleflex had a positive return on equity of 15.64% and a negative net margin of 10.28%.The firm had revenue of $892.90 million during the quarter, compared to analysts’ expectations of $892.79 million. During the same quarter in the prior year, the business earned $3.49 earnings per share. The company’s revenue was up 19.4% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 14.000-14.200 EPS. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, December 15th. Investors of record on Friday, November 14th were issued a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.4%. The ex-dividend date of this dividend was Friday, November 14th. Teleflex’s dividend payout ratio is currently -18.50%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.